News attention




Redesigned clinical trials

In 2020, applicants can expect innovation in the field of clinical trials, including more virtual or hybrid trials, adaptive trials, and other designs that better meet patient needs. In fact, the company is realizing the value of patient insights (as well as other stakeholders) for successfully conducting experiments.


Next Generation Genetics and Gene Editing

Scientists have also made significant progress in the field of gene editing. Among the most remarkable achievements this year, the United States launched the first clinical trial involving CRISPR treated cells, and began to conduct high-quality editing. The newly established Genomics Research laboratory may be carrying out more gene editing innovation, which is a facility established by cooperation between GSK plc and the original pioneer of CRISPR.


The Rise of Biosimilars and Genetics

According to the FDA, biosimilars are highly similar to existing reference products approved by the FDA, and there are no significant clinical differences. In other words, biosimilars may not necessarily contain the same active ingredients as the reference product. On the contrary, generic drugs do contain the same active ingredients as branded drugs. Biosimilars and generic drugs are usually cheaper than branded drugs, but their respective regulatory methods are different.


Extensive Wearable technology

For decades, consumers have been purchasing smart personal devices, but more and more technology companies are enabling users to track their health status. This not only enables people to monitor their health status, but also makes it easy to share this data with doctors and use it for scientific research. Recently, medical genetics company Invitae announced the launch of a mobile application that utilizes Apple Watch data to better understand the genetic basis of atrial fibrillation. Wearable devices are also being used in a new way to attract patients. A Stanford University study investigated whether children with Autism spectrum disorders could improve their social skills by using a pair of "smart" glasses to participate in facial recognition activities.


Emphasize targeted therapy

A few years ago, personalized healthcare was an emerging concept rather than a specific component of healthcare systems. However, last year, 42% of newly approved drugs, medications, or therapeutic biologics were classified as personalized drugs. Personalized medicine refers to therapies designed based on the patient's genetic and molecular composition. In principle, individualized treatment should be more effective for patients compared to non-specific drugs.


The Popularization of Artificial Intelligence (AI) and Machine Learning

In reports from PwC and Deloitte, researchers predict that this technological trend will continue until 2020. Life science companies will need to adopt these new technologies to maintain competitiveness in their respective markets.

< 1 >